ALEXANDRA PISANI: Open Payments
NPI 1003696352 · LUMBERTON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$915 in 24 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $236 · 2025 $915
Food & beverage: $915
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $261 |
| Novo Nordisk Inc | 7 | $220 |
| Madrigal Pharmaceuticals | 1 | $141 |
| Merck Sharp & Dohme LLC | 1 | $124 |
| Amgen Inc. | 3 | $45 |
| ABBVIE INC. | 2 | $39 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $37 |
| Exact Sciences Corporation | 1 | $21 |
| GlaxoSmithKline, LLC. | 1 | $15 |
| Phathom Pharmaceuticals, Inc. | 1 | $11 |
Products named: Ozempic, REZDIFFRA, CAPVAXIVE, AIRSUPRA, BREZTRI, VRAYLAR, XIFAXAN, EVENITY.
Industry payments across NJ — which companies pay providers there.
